Immune response of C57BL/6J mice to herpes zoster subunit vaccines formulated with nanoemulsion-based and liposome-based adjuvants
- 1 December 2021
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 101 (Pt B) , 108216
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- M2e-Displaying Virus-Like Particles with Associated RNA Promote T Helper 1 Type Adaptive Immunity against Influenza APLOS ONE, 2013
- TLR-based immune adjuvantsVaccine, 2011
- Interferon-γ release assay: A simple method for detection of varicella-zoster virus-specific cell-mediated immunityJournal of Immunological Methods, 2009
- Viral Load, Clinical Disease Severity and Cellular Immune Responses in Primary Varicella Zoster Virus Infection in Sri LankaPLOS ONE, 2008
- Neonatal immune response and serum bactericidal activity induced by a meningococcal conjugate vaccine is enhanced by LT-K63 and CpG2006Vaccine, 2008
- A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older AdultsNew England Journal of Medicine, 2005
- Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activitiesEuropean Journal of Immunology, 2003
- Science commentary: Th1 and Th2 responses: what are they?BMJ, 2000
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- Action of Saponin on Biological Cell MembranesNature, 1962